The continuum of ovarian response leading to birth, a real world study of ART in Spain
Background. The first biosimilar of recombinant follicle stimulating hormone (rFSH) launched in Europe was Bemfola® in 2014 following a clinical development programme demonstrating efficacy and safety to the satisfaction of the European Medicines Agency. Since then the increasing use of biosimilar r...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Publishing House TRILIST,
2021-03-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|